As the deaths caused by the coronavirus passed 190,000 at the global level and the number of cases crossed the 2.7 million threshold (Johns Hopkins University data updated Friday), a „historic collaboration“ was launched to accelerate the arrival of a vaccine.
Archiv: International Generic and Biosimilar medicines Association (IGBA)
Secretary-General‘s remarks at the launch of the Statement of Commitment and Call for Support for the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 Tools [as delivered]
This launch brings together world leaders, the private sector, scientific and humanitarian actors and other partners to promote health, keep the world safe and advance the public good.
Human health is the quintessential global public good.
And today, we face a global public enemy like no other.
$8-billion effort aims to speed development of coronavirus vaccines and treatments
Friday’s launch event was co-hosted by French President Emmanuel Macron, European Commission President Ursula von der Leyen and philanthropists Bill and Melinda Gates.
Leaders from South Africa, Rwanda, Germany, Great Britain, Spain, Italy, Malaysia, Saudi Arabia, Finland and Costa Rica joined the call to pledge their commitment to work with and support the ACT Accelerator.
Representatives from the United States and China were noticeably absent.
Global collaboration to accelerate new COVID-19 health technologies
The launch of the new collaboration is being co-hosted by WHO Director-General Dr Tedros Adhanom Ghebreyesus, Emmanuel Macron, President of the French Republic, Ursula von der Leyen, President of the European Commission, and the Bill and Melinda Gates Foundation.
The virtual event will include senior United Nations, government and public health and industry leaders from around the world.
World leaders call for global collaboration in COVID-19 fight
World leaders have joined the World Health Organisation in calling for global collaboration to accelerate the development and equitable access to new COVID-19 tools, including vaccines.